CLINICAL TRIAL OF GENE THERAPY FOR ADA-DEFICIENT SCID
- 3 Anni 2003/2006
- 2.784.422€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 2004 MOLECULAR THERAPY
IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34(+) cells while maintaining in vivo lymphoid potential
- 2004 HUMAN GENE THERAPY
Mobilized blood CD341 cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice
